Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research

Applied Cells is thrilled to announce the opening of the CellQuest Grant call to all clinical research scientists with a special interest in multiple myeloma and cell therapy development applications. This remarkable initiative, available until mid-November 2023, offers the opportunity to win a six-month placement of the company’s propriety MARS® Bar cell separation instrument, along with necessary reagents, training and assistance.

The collaborative program aims to support exceptional research projects with top-of-the-range cell separation technologies, helping to accelerate our understanding of multiple myeloma and propel the fight against the disease.This exciting award package offers unparalleled access to the company’s proprietary MARS Bar platform, which uses automated immunomagnetic separation to enrich target cells with high recovery, high purity and high reproducibility.

The prize includes a six-month placement of the MARS Bar instrument, supply of cell isolation reagents and consumables, comprehensive training, application development support, and ongoing assistance from a dedicated application scientist. Applied Cells is excited to invite researchers from around the globe to submit proposals that align with four distinct research areas.

  • Deciphering the disease: exploring the microenvironment of bone marrow in multiple myeloma.
  • Focusing on diagnostics: understanding circulating tumor cells in multiple myeloma.
  • Advancing treatment: tailored approaches for multiple myeloma therapy.
  • Improving cell therapy: improving protocols for cell-based interventions for multiple myeloma.

Applicants can learn more and apply at https://appliedcells.com/grant-2023/.Researchers interested in finding out more can connect with Liping Yu, Vice President of Applications at Applied Cells, at the 20th IMS Annual Meeting, September 27-30, to discuss this incredible grant opportunity.

Click here to book a meeting with Liping or schedule a call with an Applied Cells representative today.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Applied Cells. (2023, October 02). Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research. News-Medical. Retrieved on July 22, 2024 from https://www.news-medical.net/news/20231002/Applied-Cells-opens-CellQuest-Research-Grant-to-accelerate-cutting-edge-multiple-myeloma-research.aspx.

  • MLA

    Applied Cells. "Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research". News-Medical. 22 July 2024. <https://www.news-medical.net/news/20231002/Applied-Cells-opens-CellQuest-Research-Grant-to-accelerate-cutting-edge-multiple-myeloma-research.aspx>.

  • Chicago

    Applied Cells. "Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research". News-Medical. https://www.news-medical.net/news/20231002/Applied-Cells-opens-CellQuest-Research-Grant-to-accelerate-cutting-edge-multiple-myeloma-research.aspx. (accessed July 22, 2024).

  • Harvard

    Applied Cells. 2023. Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research. News-Medical, viewed 22 July 2024, https://www.news-medical.net/news/20231002/Applied-Cells-opens-CellQuest-Research-Grant-to-accelerate-cutting-edge-multiple-myeloma-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.